Owensboro

Kentucky BioProcessing LLC (KBP) has been awarded a patent for a veterinary vaccine produced with tobacco plants. KBP’s parvovirus vaccine, which has potential for both feline and canine applications, builds on the company’s already-patented Geneware technology, a plant-based gene expression systems that uses a specifically altered tobacco mosaic virus as a vehicle to carry a target protein. Once the altered virus is introduced into a host plant, the natural growth of the plant causes the protein to be reproduced in larger quantities.